NEW YORK (GenomeWeb News) — Sigma-Aldrich yesterday said third-quarter revenue rose 14 percent as R&D spending increased 14 percent and profit widened 5 percent.
 
Total receipts for the three months ended Sept. 30 increased to $503.2 million from $441.4 million year over year.
 
R&D spending increased to $15 million from $13.2 million year over year.
 
The company said profit increased to $71.6 million from $68.4 million in the year-ago period. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.